<DOC>
	<DOCNO>NCT01415713</DOCNO>
	<brief_summary>Phase I part , Primary objective : maximum tolerate dose S-1 SLOG regimen Secondary objective : dose-limiting toxicity regimen Phase II part , Primary objective : Overall tumor response rate ( RECIST criterion ) Secondary objective : Disease control rate ( Objective response rate ( ORR ) + stable disease â‰§ 16 week ) , Time tumor progression , Progression-free survival , Overall survival , Safety profile , Biomarker study</brief_summary>
	<brief_title>The Study Metastatic Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>Phase I : 2~24 patient Phase II : Considering design p0 = 0.25 p1 = 0.40 error 0.10 error 0.20 , constraint meet two-stage Simon 's design 25 patient first stage 27 patient second stage .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients must cyto/histologically confirm , recurrent metastatic adenocarcinoma pancreas ( mPAC ) . 2 . Patients must history prior chemotherapy . 3 . Patients prior radiotherapy . 4 . Patients ' baseline ECOG performance status must 2 . 5 . Patients ' life expectancy must 12 week great . 6 . Patients ' age must 20 75 . 7 . Patients must adequate bone marrow function . 8 . Patients must adequate liver renal function . 9 . All patient must sign give write informed consent . Exclusion criterion : 1 . Patients major abdominal surgery , radiotherapy . 2 . Patients central nervous system metastasis . 3 . Patients active infection . 4 . Pregnant breastnursing woman . 5 . Patients active cardiopulmonary disease . 6 . Patients peripheral neuropathy &gt; Grade I . 7 . Patients serious concomitant systemic disorder . 8 . Patients prior concurrent malignancy . 9 . Patients biologic treatment malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>enroll 80 patient trial</keyword>
</DOC>